TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to compare pain control after robotic hysterectomy surgery using either liposomal bupivacaine or Bupivacaine when injected during a transversus abdominis plane (TAP) block. Robotic hysterectomy is when a patient is electively having robotic assisted removal of one's uterus. Both medications liposomal bupivacaine and Bupivacaine are standard of care in these types of surgeries.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• those who present for elective robotic assisted hysterectomy

Exclusion Criteria:

• non english speaking

• chronic pain

• on opioids greater than 1 weeks

• chronic anticoagulation

• allergy to local anesthetics

• use of spinal or epidural for surgery

• lack of patient cooperation

• contraindication to regional anesthesia